It activates the PI3K/AKT and MAPK signaling cascades primarily through interaction with ALK receptors, thereby enhancing cell proliferation, survival, and anti-apoptotic signaling, particularly in neuroblastoma and glioma models. This evidence concerns the gene AKT1 and central nervous system cancer.